Speaker Profile
M.D., Ph.D., Chief Medical Officer, Mission Bio
Biography
Dr. Zivjena Vucetic is a physician-scientist with over 15 years of experience leading medical and scientific strategy across global diagnostics and emerging technologies. She has built a career translating breakthrough science into clinical adoption, spanning oncology, infectious disease, neurodegeneration, and early detection. Zivjena has held senior leadership roles across industry most recently as CMO and SVP at Beckman Coulter Diagnostics, where she directed medical strategy and advanced biomarker programs in Alzheimers and Parkinsons disease. With both an M.D. and Ph.D., Dr. Vucetic brings deep expertise in bridging clinical research, regulatory science, and market delivery to accelerate precision medicine.
Talk
Single-Cell MRD Assessment: Advancing Beyond Standard Care
Learn how single-cell MRD delivers earlier, more accurate relapse detection than current standard methods. Using dynamic multiomic signals to reduce false-negative and false-positive results, it supports more confident AML treatment decisions. Its validated high-sensitivity performance demonstrates clear clinical value for improving patient outcomes.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony
• W.E. Moerner, Stanford
• Serge Saxonov, 10x Genomics
• Priscilla Chan, CZI
Honoree Fireside
• Chair: Christina Curtis, Stanford
• W.E. Moerner, Stanford
• Priscilla Chan, CZI
• Serge Saxonov, 10x Genomics
Unraveling Tissue Architecture with Single-Cell & Spatial Multi-Omics
• Joakim Lundeberg, SciLifeLab
• Garry P. Nolan, Stanford
• Tae Hyun Hwang, Vanderbilt University Medical Center
• Michael Angelo, Stanford
Spatial Sequencing for Next Generation Pathology
• Jeremy Schurman, Singular Genomics
Precision Profiling of Cells: Insights from Imaging-Spectral Flow Cytometry and Single-Cell Multiomics
• Aruna Ayer, BD
Single-Cell Genotype and Targeted Gene Expression Assay
• Zivjena Vucetic, Mission Bio
Tumor Evolution & Clonal Dynamics: From Models to Monitoring
• Chair: Christina Curtis, Stanford
Personal Omics at Scale: What Longitudinal Profiles Add to Early Detection
• Michael Snyder, Stanford
Multi-Omics-Driven Early Detection: Beyond Liquid Biopsy
• Ash Alizadeh, Stanford
• Alex Aravanis, Moonwalk Biosciences
• Sara Ahadi, OmicsEra
AI in Molecular Diagnostics: Integrating Multi-Omics & Clinical Data
• Chair: Marina Sirota, UCSF
• Olivier Gevaert, Stanford
• Rebecca Critchley-Thorne, Castle Biosciences
• Lihua Lei, Stanford
• Yunguan Wang, Cincinnati Children's
